SOURCE: Micro Imaging Technology, Inc.

March 06, 2007 05:00 ET

Micro Imaging Technology Announces Orders From Yotsubishi Corporation

SAN CLEMENTE, CA -- (MARKET WIRE) -- March 6, 2007 --Micro Imaging Technology, Inc. (OTCBB: MMTC) announced that it has received initial orders for MIT's systems for rapid microbial identification from Yotsubishi Corporation. Michael Brennan, MIT's Chairman, stated that "It is an honor to be chosen as a system supplier for Yotsubishi Corporation -- whose core competence is providing environmental sampling and monitoring instrumentation. Significant market penetration is expected by coupling MIT's systems that are capable of detecting pathogens simply and within minutes with the proven strength of Yotsubishi's marketing and support resources. The Yotsubishi orders come after MIT's recent announcement on January 7, 2007, of an OEM Supply Agreement from San Diego-based JMAR Corporation -- these orders are starting MIT's year off on a very positive note."

About Yotsubishi Corporation:

Yotsubishi Corporation is a SIBATA SCIENTIFIC TECHNOLOGY Ltd. Group company responsible for all export businesses and global expansion. SIBATA was founded in 1921 as a laboratory glassware manufacturer and has successfully expanded as a leading innovator in the medical, chemical and environmental-measuring field in Japan. Through the years, SIBATA has developed and modified various technologies including Beta-ray attenuation, light-scattering, pressure-resistant sampling pumps for environmental testing and measuring methods that are in use worldwide. Yotsubishi is located in Chiyoda-ku Tokyo 101-0053, Japan and can be reached at e-mail: sales@yotsubishi.com

About Micro Imaging Technology:

MIT has developed and patented a laser-based technology for rapid microbe detection and identification. The system measures scattered light intensity as individual microbes pass through a laser beam. The intensity pattern of the scattered light is a direct consequence of the size, shape and external and internal optical characteristics of the microbe. The MIT System is non-biological and does not rely on biological agents, conventional chemical processing, fluorescent tags, gas chromatography or DNA analysis.

MIT has demonstrated the ability to detect and identify, within minutes, the microbes Escherichia coli, Listeria, Salmonella, Staphylococcus aureus, Shigella and other pathogenic bacteria and protozoa; including Cryptosporidium and Giardia. The identification process has been tested and verified by North American Science Associates, Inc. (NAMSA), an independent and internationally recognized testing and certification laboratory. The NAMSA Test Report, available from the Company, confirms the accuracy, speed and efficiency of the MIT system over conventional processes.

This release contains statements that are forward looking in nature. Statements that are predictive in nature, that depend upon or refer to future events or conditions or that include words such as "expects," "anticipates," "intends," "plans," "believes," "estimates," and similar expressions are forward-looking statements. These statements are made based upon information available to the Company as of the date of this release, and we assume no obligation to update any such forward-looking statements. These statements are not guarantees of future performance and actual results could differ materially from our current expectations. Factors that could cause or contribute to such differences include, but are not limited to dependence on suppliers; short product life cycles and reductions in unit selling prices; delays in development or shipment of new products; lack of market acceptance of our new products or services; inability to continue to develop competitive new products and services on a timely basis; introduction of new products or services by major competitors; our ability to attract and retain qualified employees; inability to expand our operations to support increased growth; and declining economic conditions, including a recession. These and other factors and risks associated with our business are discussed from time to time within our filings with the Securities and Exchange Commission.

Contact Information

  • FOR FURTHER INFORMATION, CONTACT:
    Michael Brennan
    Chairman
    Micro Imaging Technology, Inc.
    Email: Email Contact
    Phone: (805) 557-0614